Oncology PracticeFDA approves first generic capecitabineSeptember 16, 2013Breast CancerGastroenterologyGI OncologyGastrointestinal Cancer
Oncology PracticeFear, anxiety drive contralateral mastectomy, survey findsSeptember 16, 2013Breast Cancer
Oncology PracticeFDA advisory panel backs approval of neoadjuvant pertuzumab for breast cancerSeptember 13, 2013Breast Cancer
Oncology PracticeMammoSite has comparatively high long-term complication rateSeptember 12, 2013Breast Cancer
Oncology PracticeResponse-guided neoadjuvant chemotherapy may boost survivalSeptember 10, 2013Breast Cancer
Oncology PracticeAbbreviated MRI breast cancer screening protocol accurateSeptember 9, 2013Breast Cancer
Oncology PracticePerioperative MRI fails to reduce recurrence risk in women with ductal carcinoma in situSeptember 5, 2013Breast Cancer
Oncology PracticeNo increase in cardiovascular risk seen after radiation therapy for DCIS September 4, 2013Breast Cancer
The Journal of Community and Supportive OncologyMinimizing cancer’s impact on bone with denosumab: current and future perspectivesSeptember 4, 2013Breast CancerGenitourinary CancerPatient & Survivor CarePractice ManagementBusiness of Medicine
The Journal of Community and Supportive OncologyOccult cancer: suspected breast and BRCA gene mutationsSeptember 3, 2013Breast Cancer
Oncology PracticeAdjuvant ibandronate adds no benefit in early stage, node-positive breast cancerAugust 27, 2013Breast Cancer
Oncology PracticeLong-term amenorrhea risk no higher for premenopausal breast cancer patients with BRCA mutationsAugust 27, 2013Breast Cancer
Oncology PracticeLymph node status predicted 10-year mortality in BRCA1 mutation carriers with small, stage I-III breast cancersAugust 27, 2013Breast Cancer
